Mrinal M. Gounder, MD

Associate Attending Physician
Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center
New York, New York, United States

I am a medical oncologist specializing in treating bone and soft tissue sarcoma. I specialize in clinical trials of early to late-stage (phase I, II, III) drugs across all solid tumors including sarcoma. I practice at Memorial Sloan Kettering Cancer center in New York and have over 10 years of experience in drug development and clinical trials.

Presentation(s):

• Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA

  Thursday, November 17, 2022
  1:16 PM – 1:24 PM

• Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA

  Thursday, November 17, 2022
  1:24 PM – 1:32 PM

• Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS

  Saturday, November 19, 2022
  1:30 PM – 1:42 PM

• Paper 81 - PSYCHOMETRIC PROPERTIES AND MEANINGFUL CHANGE THRESHOLDS (MCT) OF THE GOUNDER/DESMOID TUMOR RESEARCH FOUNDATION DESMOID SYMPTOM/IMPACT SCALE (GODDESS) AS ASSESSED IN THE PHASE 3 DEFI TRIAL

  Saturday, November 19, 2022
  1:30 PM – 1:42 PM

• Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE

  Saturday, November 19, 2022
  4:36 PM – 4:44 PM